TY - JOUR
T1 - Mild cognitive impairment
T2 - Statistical models of transition using longitudinal clinical data
AU - Abner, Erin L.
AU - Kryscio, Richard J.
AU - Cooper, Gregory E.
AU - Fardo, David W.
AU - Jicha, Gregory A.
AU - Mendiondo, Marta S.
AU - Nelson, Peter T.
AU - Smith, Charles D.
AU - Van Eldik, Linda J.
AU - Wan, Lijie
AU - Schmitt, Frederick A.
PY - 2012
Y1 - 2012
N2 - Mild cognitive impairment (MCI) refers to the clinical state between normal cognition and probable Alzheimer's disease (AD), but persons diagnosed with MCI may progress to non-AD forms of dementia, remain MCI until death, or recover to normal cognition. Risk factors for these various clinical changes, which we term transitions, may provide targets for therapeutic interventions. Therefore, it is useful to develop new approaches to assess risk factors for these transitions. Markov models have been used to investigate the transient nature of MCI represented by amnestic single-domain and mixed MCI states, where mixed MCI comprised all other MCI subtypes based on cognitive assessments. The purpose of this study is to expand this risk model by including a clinically determined MCI state as an outcome. Analyses show that several common risk factors play different roles in affecting transitions to MCI and dementia. Notably, APOE-4 increases the risk of transition to clinical MCI but does not affect the risk for a final transition to dementia, and baseline hypertension decreases the risk of transition to dementia from clinical MCI.
AB - Mild cognitive impairment (MCI) refers to the clinical state between normal cognition and probable Alzheimer's disease (AD), but persons diagnosed with MCI may progress to non-AD forms of dementia, remain MCI until death, or recover to normal cognition. Risk factors for these various clinical changes, which we term transitions, may provide targets for therapeutic interventions. Therefore, it is useful to develop new approaches to assess risk factors for these transitions. Markov models have been used to investigate the transient nature of MCI represented by amnestic single-domain and mixed MCI states, where mixed MCI comprised all other MCI subtypes based on cognitive assessments. The purpose of this study is to expand this risk model by including a clinically determined MCI state as an outcome. Analyses show that several common risk factors play different roles in affecting transitions to MCI and dementia. Notably, APOE-4 increases the risk of transition to clinical MCI but does not affect the risk for a final transition to dementia, and baseline hypertension decreases the risk of transition to dementia from clinical MCI.
UR - http://www.scopus.com/inward/record.url?scp=84859783666&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84859783666&partnerID=8YFLogxK
U2 - 10.1155/2012/291920
DO - 10.1155/2012/291920
M3 - Article
C2 - 22536535
AN - SCOPUS:84859783666
SN - 2090-8024
JO - International Journal of Alzheimer's Disease
JF - International Journal of Alzheimer's Disease
M1 - 291920
ER -